Matricelf Ltd. Logo

Matricelf Ltd.

Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.

MTLF | TA

Overview

Corporate Details

ISIN(s):
IL0011767915
LEI:
Country:
Israel
Address:
3 Golda Meir Street, 7651713 Ness Zion
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Matricelf is a preclinical-stage biotechnology company specializing in personalized regenerative medicine. The company develops a proprietary platform for autologous 3D tissue engineering, which creates functional neural implants from a patient's own cells. The technology combines induced Pluripotent Stem Cells (iPSCs) with a personalized hydrogel derived from the patient's extracellular matrix (ECM). This approach is designed to create fully compatible, engineered tissues that promote regeneration without the risk of immune rejection. Matricelf's primary focus is on developing a one-time, curative solution for spinal cord injuries, with its platform also holding potential for treating other conditions such as stroke, traumatic brain injury, and myocardial infarction.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-08 20:40
Investor Presentation
COMPANY'S PRESENTATION
Hebrew (modern) 2.3 MB
2024-09-08 20:40
Pre-Annual General Meeting Information
COMPANY'S PRESENTATION
Russian 42.8 KB
2024-03-27 15:30
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2024-03-27 15:30
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 43.3 KB
2023-02-14 16:31
Investor Presentation
Corporate Presentation - February2023
English 1.1 MB
2023-02-14 16:31
Regulatory News Service
Corporate Presentation - February2023
Russian 42.7 KB
2022-03-16 10:59
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2022-03-16 10:59
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 41.6 KB
2021-06-17 18:14
Regulatory News Service
Opening of Trading On Sunday June 20, 2021, Appointment of a Market Maker
Hebrew (modern) 256.5 KB
2021-06-14 14:20
Regulatory News Service
Identifying Details of New Security: MATRICELF, MATRICELF.W1
Hebrew (modern) 177.2 KB

Automate Your Workflow. Get a real-time feed of all Matricelf Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Matricelf Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Matricelf Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America ACET
Adlai Nortye Ltd. Logo
Clinical-stage biopharma developing innovative targeted and immuno-oncology therapies.
United States of America ANL
ADMA BIOLOGICS, INC. Logo
End-to-end biopharma making plasma-derived biologics for immune-compromised patients.
United States of America ADMA
Adverum Biotechnologies, Inc. Logo
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
United States of America ADVM
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AEON Biopharma, Inc. Logo
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan 2927
AGENUS INC Logo
Develops antibodies, cell therapies & adjuvants to harness the immune system against cancer.
United States of America AGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.